The Expression of Androgen Receptor and Its Variants in Human Prostate Cancer Tissue according to Disease Status, and Its Prognostic Significance

The Expression of Androgen Receptor and Its Variants in Human Prostate Cancer Tissue according to Disease Status, and Its Prognostic Significance

Purpose: To evaluate changes in the expression of androgen receptor (AR) and its variants (ARVs) in human prostate cancer (PCa) tissues according to disease status, and its prognostic significance following radical prostatectomy (RP). Materials and Methods: A total of 282 PCa cases were evaluated,...

Full description

Bibliographic Details
Main Authors:	Sung-Woo Park, Jung Hee Kim, Hyun Jung Lee, Dong Hoon Shin, Sang Don Lee, Sik Yoon
Format:	Article
Language:	English
Published:	Korean Society for Sexual Medicine and Andrology 2019-01-01
Series:	The World Journal of Men's Health
Subjects:	Prostatectomy Prostatic neoplasms Androgen receptors Survival Tissue banks

Similar Items

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
by: Bianchi, R., et al.
Published: (2022)

Impact of age on the biochemical failure and androgen suppression after radical prostatectomy for prostate cancer in chilean men
by: Nigel P Murray, et al.
Published: (2016-01-01)

SUBSTITUTION ANDROGEN THERAPY AFTER RADICAL TREATMENT OF PROSTATE CANCER
by: T. Kh. Nazarov, et al.
Published: (2018-05-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
by: Ken-ichi Takayama, et al.
Published: (2017-08-01)

Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01)

Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
by: Satoru Ueno, et al.
Published: (2018-03-01)

The characteristics of androgen receptor splice variant 7 in the treatment of hormonal sensitive prostate cancer: a systematic review and meta-analysis
by: Zhize Wang, et al.
Published: (2020-05-01)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
by: Nicolaas Lumen, et al.
Published: (2021-07-01)

Androgen Receptor Roles in Benign and Malignant Prostate Disease
Published: (2011-06-01)

Prognostic significance of genetic polymorphisms in disease progression and survival in prostate cancer after androgen deprivation therapy
by: Tsung-Yi Huang, et al.
Published: (2015-06-01)

The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
by: Hoon Choi, et al.
Published: (2016-12-01)

Androgens and prostate disease
by: Lori A Cooper, et al.
Published: (2014-04-01)

Maximal androgen blockade for advanced prostate cancer
by: Rajiv Paul Mukha, et al.
Published: (2010-01-01)

Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
by: Nurul Azwa Abd. Wahab, et al.
Published: (2020-03-01)

Stromal Androgen Receptor in Prostate Cancer Development and Progression
by: Damien A. Leach, et al.
Published: (2017-01-01)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
by: Zoran Culig
Published: (2021-06-01)

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
by: Namrata Khurana, et al.
Published: (2020-01-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
by: Sirin Saranyutanon, et al.
Published: (2019-12-01)

Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study
by: Tommaso Castelli, et al.
Published: (2014-06-01)

Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2021-03-01)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
by: Thiago N. Valette, et al.
Published: (2015-06-01)

Zinc Inhibits Expression of Androgen Receptor to Suppress Growth of Prostate Cancer Cells
by: Phuong Kim To, et al.
Published: (2018-10-01)

Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
by: Hongzoo Park, et al.
Published: (2020-01-01)

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
by: Alshalalfa, M., et al.
Published: (2022)

Role of maximum androgen blockade in advanced prostate cancer
by: Rajinikanth Ayyathurai, et al.
Published: (2009-01-01)

Giant prostatic hyperplasia and its causes
by: Marius Anglickis, et al.
Published: (2020-04-01)

Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer
by: Mauro Scaravilli, et al.
Published: (2021-02-01)

Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancer
by: Tianfang Ma, et al.
Published: (2021-02-01)

Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy
by: Minyong Kang, et al.
Published: (2018-01-01)

Does a previous prostate biopsy-related acute bacterial prostatitis affect the results of radical prostatectomy?
by: Hakan Türk, et al.

Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
by: Eva Estébanez-Perpiñá, et al.
Published: (2021-01-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND FREE ANDROGEN INDEX IN PATIENTS WITH PROSTATE CANCER
by: M. E. Grigoryev, et al.
Published: (2014-08-01)

PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND FREE ANDROGEN INDEX IN PATIENTS WITH PROSTATE CANCER
by: M. E. Grigoryev, et al.
Published: (2014-08-01)

Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data
by: Byeong Jo Jeon, et al.
Published: (2019-03-01)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
by: Day Wanda V, et al.
Published: (2005-04-01)

Plasma Androgen Receptor in Prostate Cancer
by: Vincenza Conteduca, et al.
Published: (2019-11-01)

Non-interventional study of treatment approaches in patients with locally advanced prostate cancer who have undergone prostatectomy or radiation therapy (PREVENT)
by: V. B. Matveev, et al.
Published: (2020-11-01)